Literature DB >> 7139655

High-dose metoclopramide in cancer chemotherapy-induced nausea and vomiting.

N B Bui, G Marit, B Hoerni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139655

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  6 in total

1.  GR38032F, a 5HT3 receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting.

Authors:  M Marty; J P Droz; P Pouillart; B Paule; N Brion; J Bons
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.

Authors:  S G Allan; M A Cornbleet; P S Warrington; I M Golland; R C Leonard; J N Smyth
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-06

3.  A randomised cross-over trial comparing low-dose metoclopramide and chlorpromazine with high-dose metoclopramide in Chinese patients with advanced cancer receiving cisplatinum and 5-fluorouracil.

Authors:  W Shiu; V Tsang; Y M Lam; A Zacharia; W M Martin
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination.

Authors:  N B Bui; J Chauvergne; C Hocke; M Durand; R Brunet; J M Coindre
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy.

Authors:  R A Joss; R L Galeazzi; K W Brunner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.